| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |